Novan Inc (NASDAQ:NOVN) hit a new 52-week low during mid-day trading on Friday . The stock traded as low as $3.40 and last traded at $4.24, with a volume of 19900 shares trading hands. The stock had previously closed at $4.30.
Several equities research analysts have issued reports on the stock. ValuEngine upgraded shares of Novan from a “strong sell” rating to a “sell” rating in a research note on Sunday, December 31st. Wedbush reiterated a “neutral” rating and issued a $6.00 price target on shares of Novan in a research note on Monday, September 25th. Finally, Zacks Investment Research upgraded shares of Novan from a “sell” rating to a “hold” rating in a research note on Wednesday, October 4th.
The stock has a market cap of $57.73 and a P/E ratio of -1.97.
COPYRIGHT VIOLATION NOTICE: “Novan (NOVN) Reaches New 52-Week Low at $3.40” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at https://www.tickerreport.com/banking-finance/3127305/novan-novn-reaches-new-52-week-low-at-3-40.html.
Novan Company Profile
Novan, Inc is a late-stage pharmaceutical company. The Company is engaged in the development and commercialization of therapies using its nitric oxide platform. The Company develops product candidates using its Nitricil technology, which enables the Company to engineer tunable new chemical entities (NCEs).
Receive News & Ratings for Novan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novan and related companies with MarketBeat.com's FREE daily email newsletter.